Stacy Hung

BC Cancer Agency — Canada

Medicine · Health Sciences

17h-index2.3kcitations49works0.72yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Lymphoma Diagnosis and Treatment(28), Cancer Genomics and Diagnostics(10), CAR-T cell therapy research(8), Chronic Lymphocytic Leukemia Research(7), Single-cell and spatial transcriptomics(6)

Publications49 total

Multidimensional Characterization of Tumor–Immune Architecture Reveals Clinically Relevant Classic Hodgkin Lymphoma Subtypes
Cancer Discovery·2026
Tumor microenvironment differences between diagnostic and relapsed classic Hodgkin lymphoma revealed by scRNA-seq
Blood Advances·2025Open Access
Multidimensional characterization of cellular ecosystems in Hodgkin lymphoma
2025· 1 citedOpen Access
Tumor Microenvironment Differences between Diagnostic and Relapsed Classic Hodgkin Lymphoma Revealed By Single Cell Transcriptome Sequencing
Blood·2024
ANTI-CANCER CHARACTERISTICS OF PERSONALIZED NEOANTIGEN-BASED T-CELL THERAPY FOR SOLID TUMORS
Cytotherapy·2024
A Trial of Small-Scale Crowdsourcing to Achieve Group Learning Competencies in Clinical Chemistry
Academic Pathology·2024Open Access
Chronic Lymphocytic Leukemia IGHV Somatic Hypermutation Detection by Targeted Capture Next-Generation Sequencing
Clinical Chemistry·2024· 4 citedOpen Access
Multi-Dimensional Molecular and Tumor-Microenvironment Analysis of Classic Hodgkin Lymphoma
Blood·2023· 9 cited
Single-cell profiling reveals a memory B cell-like subtype of follicular lymphoma with increased transformation risk
Nature Communications·2022· 28 citedOpen Access
An Open-Source Toolkit That Powers the Genome-Wide Analysis of Mature B-Cell Lymphomas (GAMBL) Project
Blood·2021· 1 citedOpen Access
Single-Cell Profiling Reveals Clinically Relevant Evolutionary Trajectories and Alternate Biologies in Human Follicular Lymphoma
Blood·2021
Immune Profiling of Diagnostic DLBCL Biopsies Dramatically Improves upon Cell-of-Origin Risk Stratification
Blood·2021· 1 cited
Characterization of DLBCL with a PMBL gene expression signature
Blood·2021· 34 citedOpen Access
The Tumor Associated Antigen PRAME Exhibits Dualistic Functions That Are Targetable in Diffuse Large B-Cell Lymphoma
Blood·2020· 5 cited
Abstract PO-18: Comprehensive correlation between genetic alterations in DLBCL and deregulated activation of the PI3K-AKT pathway isolates unique players in lymphoma dissemination and inferior outcome
Blood Cancer Discovery·2020
Activation-induced cytidine deaminase localizes to G-quadruplex motifs at mutation hotspots in lymphoma
NAR Cancer·2020· 21 citedOpen Access
Mutational landscape of gray zone lymphoma
Blood·2020· 103 citedOpen Access
Brentuximab vedotin in combination with rituximab, cyclophosphamide, doxorubicin, and prednisone as frontline treatment for patients with CD30-positive B-cell lymphomas
Haematologica·2020· 51 citedOpen Access
Mutational Landscape of Grey Zone Lymphoma
Blood·2019· 6 cited
Diffuse Large B-Cell Lymphomas with a Molecular PMBCL Expression Signature Represent a Distinct Molecular Subtype Associated with Poor Clinical Outcome
Blood·2019· 1 cited
page 1 of 3Next →

Frequent Co-authors

Christian Steidl(36), David W. Scott(22), Elizabeth A. Chavez(21), Randy D. Gascoyne(18), Kerry J. Savage(16), Clémentine Sarkozy(14), Susana Ben‐Neriah(14), Anja Mottok(13), Adèle Telenius(13), Elena Viganò(12), Gerben Duns(12), Bruce W. Woolcock(11), Tomohiro Aoki(11), Katsuyoshi Takata(10), Aixiang Jiang(10), Daisuke Ennishi(10), Andrew P. Weng(10), Lauren C. Chong(9), Ryan D. Morin(9), John Parkinson(8)